NK cytotoxicity against CD4+ T cells during HIV-1 infection: A gp41 peptide induces the expression of an NKp44 ligand

V Vieillard, JL Strominger… - Proceedings of the …, 2005 - National Acad Sciences
V Vieillard, JL Strominger, P Debré
Proceedings of the National Academy of Sciences, 2005National Acad Sciences
HIV infection leads to a state of chronic immune activation and progressive deterioration in
immune function, manifested most recognizably by the progressive depletion of CD4+ T
cells. A substantial percentage of natural killer (NK) cells from patients with HIV infection are
activated and express the natural cytotoxicity receptor (NCR) NKp44. Here we show that a
cellular ligand for NKp44 (NKp44L) is expressed during HIV-1 infection and is correlated
with both the progression of CD4+ T cell depletion and the increase of viral load. CD4+ T …
HIV infection leads to a state of chronic immune activation and progressive deterioration in immune function, manifested most recognizably by the progressive depletion of CD4+ T cells. A substantial percentage of natural killer (NK) cells from patients with HIV infection are activated and express the natural cytotoxicity receptor (NCR) NKp44. Here we show that a cellular ligand for NKp44 (NKp44L) is expressed during HIV-1 infection and is correlated with both the progression of CD4+ T cell depletion and the increase of viral load. CD4+ T cells expressing this ligand are highly sensitive to the NK lysis activity mediated by NKp44+ NK cells. The expression of NKp44L is induced by the linear motif NH2-SWSNKS-COOH of the HIV-1 envelope gp41 protein. This highly conserved motif appears critical to the sharp increase in NK lysis of CD4+ T cells from HIV-infected patients. These studies strongly suggest that induction of NKp44L plays a key role in the lysis of CD4+ T cells by activated NK cells in HIV infection and consequently provide a framework for considering how HIV-1 may use NK cell immune surveillance to trigger CD4+ T cells. Understanding this mechanism may help to develop future therapeutic strategies and vaccines against HIV-1 infection.
National Acad Sciences